Transplant-free survival in acute liver failure patients receiving MARS®, plasma exchange or no liver support. A real-life 21-year retrospective cohort study in a referral center
MARS therapy improved TFS only in patients who received ≥ 3 sessions. Compared with controls, HVPE-treated patients experienced improved transplant-free and overall survival.
Authors
- Florian Reizine (ORCID: https://orcid.org/0000-0002-9871-636X)
- Pauline Houssel‐Debry (ORCID: https://orcid.org/0000-0001-9271-9810)
- Adel Maamar (ORCID: https://orcid.org/0000-0001-8352-3613)
- Edouard Bardou‐Jacquet (ORCID: https://orcid.org/0000-0002-0784-0710)
- Quentin Quelven
- Benoît Painvin (ORCID: https://orcid.org/0000-0002-0320-9876)
- Karim Boudjéma (ORCID: https://orcid.org/0000-0002-3894-8767)
- Pauline Guillot
- Flora Delamaire (ORCID: https://orcid.org/0000-0002-9674-4391)
- Christophe Camus (ORCID: https://orcid.org/0000-0002-2055-3003)
- Mathieu Lesouhaitier (ORCID: https://orcid.org/0000-0002-3404-981X)
- Kieran Pinceaux
- Jean‐Marc Tadié (ORCID: https://orcid.org/0000-0002-7604-4849)
- Arnaud Gacouin (ORCID: https://orcid.org/0000-0003-0239-9900)
- Estelle Le Pabic (ORCID: https://orcid.org/0000-0001-9796-1294)
- Félicie Belicard
- Valentin Coirier (ORCID: https://orcid.org/0000-0002-2848-3097)
Institutions
- CIC Rennes (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
- Université de Rennes (FR)
Publication Details
- Journal
- Annals of Intensive Care
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1186/s13613-025-01506-3
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00